- Home
- CODX vs APM Comparison
CODX vs APM Comparison
Compare CODX & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODX
- APM
- Stock Information
- Founded
- CODX 2013
- APM 2010
- Country
- CODX United States
- APM United Kingdom
- Employees
- CODX N/A
- APM N/A
- Industry
- CODX Medical/Dental Instruments
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- CODX Health Care
- APM Health Care
- Exchange
- CODX Nasdaq
- APM Nasdaq
- Market Cap
- CODX 16.9M
- APM 18.9M
- IPO Year
- CODX 2017
- APM 2018
- Fundamental
- Price
- CODX $0.39
- APM $2.41
- Analyst Decision
- CODX Buy
- APM
- Analyst Count
- CODX 2
- APM 0
- Target Price
- CODX $2.00
- APM N/A
- AVG Volume (30 Days)
- CODX 14.5M
- APM 348.5K
- Earning Date
- CODX 11-06-2025
- APM 04-30-2025
- Dividend Yield
- CODX N/A
- APM N/A
- EPS Growth
- CODX N/A
- APM N/A
- EPS
- CODX N/A
- APM N/A
- Revenue
- CODX $1,003,653.00
- APM N/A
- Revenue This Year
- CODX N/A
- APM N/A
- Revenue Next Year
- CODX $31.58
- APM N/A
- P/E Ratio
- CODX N/A
- APM N/A
- Revenue Growth
- CODX N/A
- APM N/A
- 52 Week Low
- CODX $0.23
- APM $0.46
- 52 Week High
- CODX $1.40
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- CODX 48.59
- APM 55.03
- Support Level
- CODX $0.32
- APM $1.86
- Resistance Level
- CODX $0.41
- APM $2.45
- Average True Range (ATR)
- CODX 0.04
- APM 0.18
- MACD
- CODX -0.01
- APM 0.03
- Stochastic Oscillator
- CODX 28.99
- APM 51.90
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.